<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Preoxygenation and apneic oxygenation for airway management for anesthesia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Preoxygenation and apneic oxygenation for airway management for anesthesia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Preoxygenation and apneic oxygenation for airway management for anesthesia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carin A Hagberg, MD, FASA</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephanie B Jones, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marianna Crowley, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 16, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2487357583"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Preoxygenation, or administration of oxygen prior to induction of anesthesia, is an essential component of airway management. Preoxygenation is used to increase oxygen reserves in order to prevent hypoxemia during apnea. Preoxygenation and apneic oxygenation are particularly beneficial if manual ventilation after induction of anesthesia is undesirable (eg, during rapid sequence induction and intubation [RSII]), if difficulty with airway management is anticipated, and for patients who are expected to desaturate rapidly (eg, obese, pregnant, pediatric, or hypermetabolic patients).</p><p>Novel techniques have been developed that allow for preoxygenation and continued oxygenation during attempts to secure the airway, thereby preventing or delaying oxygen desaturation, and reducing time pressure during airway management. </p><p>This topic will discuss the principles and techniques for preoxygenation and for apneic oxygenation. Other aspects of airway management for anesthesia and outside the operating room are discussed separately in numerous topics. (See  <a class="medical medical_review" href="/d/html/91218.html" rel="external">"Airway management for induction of general anesthesia"</a> and  <a class="medical medical_review" href="/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/d/html/94214.html" rel="external">"Rapid sequence induction and intubation (RSII) for anesthesia"</a> and  <a class="medical medical_review" href="/d/html/90615.html" rel="external">"Management of the difficult airway for general anesthesia in adults"</a>.)</p><p class="headingAnchor" id="H822851251"><span class="h1">GOALS FOR PREOXYGENATION</span><span class="headingEndMark"> — </span>The functional goal for both preoxygenation and apneic oxygenation is to prolong the safe apnea time (or duration of apnea without desaturation [DAWD]). Safe apnea time is typically defined as the time from cessation of breathing or ventilation until the peripheral arterial oxygen saturation (SpO<sub>2</sub>)<sub> </sub>declines to 90 percent, after which it falls precipitously [<a href="#rid1">1-3</a>]. (See <a class="local">'Physiology of apnea'</a> below.)</p><p>Arterial oxyhemoglobin desaturation is a dangerous event, with prolonged desaturation leading to dysrhythmias, hemodynamic decompensation, hypoxic brain injury, and ultimately death [<a href="#rid4">4,5</a>]. Preoxygenation delays desaturation by increasing oxygen reserves; preoxygenation to a fraction of expired oxygen (FEO<sub>2</sub>) of 0.9 in a healthy patient prolongs the safe apnea time to eight minutes, compared with one minute in the same patient breathing room air [<a href="#rid6">6,7</a>]. Continued oxygenation during apnea prolongs the safe apnea time significantly further, depending on the apneic oxygenation technique and patient factors. (See <a class="local">'Apneic oxygenation'</a> below.)</p><p>The importance of preoxygenation both before intubation and before extubation has been emphasized in guidelines by the American Society of Anesthesiologists and other international anesthesia organizations, and it has become a minimum standard of care during induction and emergence from anesthesia [<a href="#rid6">6,8-12</a>]. </p><p>Prolonging the time to desaturation after induction of anesthesia reduces the time pressure to secure an airway, thereby reducing anxiety and increasing operator performance [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H3253378449"><span class="h1">OXYGEN STORAGE</span><span class="headingEndMark"> — </span>Oxygen<sub> </sub>stored in the body is quickly depleted when oxygen supply and ventilation are interrupted. Effective preoxygenation will increase the total body stores of oxygen and thereby lengthen the time until depletion occurs. The largest stores of oxygen in the human body are in the blood and in the lungs  (<a class="graphic graphic_table graphicRef119561" href="/d/graphic/119561.html" rel="external">table 1</a>). Optimal preoxygenation can increase lung oxygen stores approximately six times compared with breathing room air, depending on patient factors  (<a class="graphic graphic_figure graphicRef119612" href="/d/graphic/119612.html" rel="external">figure 1</a> and <a class="graphic graphic_table graphicRef119561" href="/d/graphic/119561.html" rel="external">table 1</a>). </p><p class="headingAnchor" id="H1387150285"><span class="h2">Oxygen storage in the lungs</span><span class="headingEndMark"> — </span>Gas in the lungs is stored primarily in the lung space defined by functional residual capacity (FRC), which is the volume of the lungs at the end of a normal tidal breath. Factors affecting FRC include body size, sex, age, posture, ethnic origin, and body habitus. </p><p>The alveolar gas in a healthy patient breathing room air with normal tidal ventilation contains approximately 14 percent oxygen, 5 percent carbon dioxide, 6 percent water vapor, and 75 percent nitrogen. If the same patient breathes 100 percent oxygen, alveolar nitrogen is progressively "washed out" and replaced with oxygen. The process of preoxygenation involves this progressive replacement of nitrogen for oxygen in the lung space defined by the FRC. (See  <a class="medical medical_review" href="/d/html/1647.html" rel="external">"Measures of oxygenation and mechanisms of hypoxemia", section on 'Alveolar-arterial (A-a) oxygen gradient'</a>.)</p><p>A change in FRC can clearly have a significant impact on the size of the oxygen reservoir within the lungs, and therefore on the efficacy of preoxygenation. Thus, patients with reduced FRC (obese, pregnant, or pediatric patients) have reduced oxygen reserves and are at increased risk of desaturation during apnea  (<a class="graphic graphic_figure graphicRef118559" href="/d/graphic/118559.html" rel="external">figure 2</a> and <a class="graphic graphic_table graphicRef120162" href="/d/graphic/120162.html" rel="external">table 2</a>). (See <a class="local">'Efficacy'</a> below.) </p><p class="headingAnchor" id="H1292475968"><span class="h1">PHYSIOLOGY OF APNEA</span><span class="headingEndMark"> — </span>After the onset of apnea, oxygen is consumed from the alveoli at a rate of approximately 250 mL per minute, while carbon dioxide is excreted into the alveoli at a rate of 20 mL per minute [<a href="#rid14">14</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fall in oxygenation during apnea</strong> – During apnea, as the alveolar partial pressure of oxygen (PAO<sub>2</sub>) falls there is a corresponding fall in the arterial partial pressure of oxygen (PaO<sub>2</sub>). The oxyhemoglobin dissociation curve defines the relationship between the partial pressure of oxygen in the blood and the oxygen saturation of hemoglobin  (<a class="graphic graphic_figure graphicRef81216" href="/d/graphic/81216.html" rel="external">figure 3</a>). (See  <a class="medical medical_review" href="/d/html/7072.html" rel="external">"Structure and function of normal hemoglobins"</a>.)</p><p></p><p class="bulletIndent1">The sigmoid shaped curve is relatively flat above a PaO<sub>2</sub> of approximately 60 mmHg (8 kPa); this represents the point at which arterial oxygen saturation (SaO<sub>2</sub>) is 90 percent. The flatness of the curve means that above a PaO<sub>2</sub> of 60 mmHg, the SaO<sub>2</sub> remains relatively constant even when there is variation in the pressure of inspired oxygen. Below a critical PaO<sub>2</sub> of 60 mmHg (which corresponds to SaO<sub>2</sub> of 90 percent) the oxyhemoglobin dissociation curve becomes a steep, almost vertical line, and small decreases in the PaO<sub>2</sub> result in a large corresponding fall in the SaO<sub>2. </sub>The sigmoid shape of the curve, along with the signal averaging used by pulse oximeters, means that peripheral arterial oxygen saturation (SpO<sub>2</sub>) is a late indicator of impending severe hypoxemia. (See  <a class="medical medical_review" href="/d/html/1612.html" rel="external">"Pulse oximetry", section on 'Advantages and disadvantages'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Increase in carbon dioxide during apnea</strong> – Carbon dioxide is 20 times more water soluble than oxygen. Once apnea occurs, carbon dioxide is excreted into the alveoli at approximately 20 mL per minute, while 90 percent of carbon dioxide remains dissolved in plasma and tissues. The arterial partial pressure of carbon dioxide (PaCO<sub>2</sub>) rises approximately 8 to 16 mmHg per minute during the first minute of apnea, with a subsequent rise of approximately 3 mmHg per minute during continued apnea, ultimately causing hypercarbia and acidosis [<a href="#rid14">14</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alveolar pressure during apnea </strong>– Initially during apnea, the difference between the amount of oxygen removed from the alveoli (approximately 250 mL/min) and the amount of carbon dioxide excreted into the alveoli (approximately 20 mL/min) creates a negative pressure gradient between the alveoli and the upper airway. Thus the gas in the oropharynx moves down the trachea into the alveoli. This phenomenon is the basis for apneic oxygenation. (See <a class="local">'Apneic oxygenation'</a> below.)</p><p></p><p class="headingAnchor" id="H2649773078"><span class="h1">EFFICACY AND EFFICIENCY OF PREOXYGENATION</span><span class="headingEndMark"> — </span>Preoxygenation can be defined in terms of efficiency and efficacy. Effective preoxygenation occurs when alveolar, arterial, tissue, and venous compartments are all maximally filled with oxygen. Efficiency is defined by the rate of decline in arterial oxygen saturation (SaO<sub>2</sub>) [<a href="#rid15">15-18</a>]; the slower the rate of decline the more efficient the preoxygenation process is  (<a class="graphic graphic_table graphicRef120162" href="/d/graphic/120162.html" rel="external">table 2</a>). </p><p class="headingAnchor" id="H703755567"><span class="h2">Efficacy</span><span class="headingEndMark"> — </span>Efficacy has been defined in terms of alveolar oxygenation, alveolar denitrogenation, or the arterial partial pressure of oxygen (PaO<sub>2</sub>) achieved by preoxygenation. In healthy patients preoxygenation typically increases the PaO<sub>2</sub> from approximately 80 mmHg to 400 mmHg [<a href="#rid19">19</a>]. In most clinical situations, the end-tidal oxygen concentration (EtO<sub>2</sub>) is used to assess efficacy, with an EtO<sub>2</sub> of 90 percent considered an adequate target [<a href="#rid6">6,15</a>]. Importantly, EtO<sub>2</sub> can be considered an accurate endpoint for preoxygenation only if it is accompanied by a normal capnogram and appropriate movement of the reservoir bag during respiration. Absent these findings, the EtO<sub>2</sub> may reflect sampling of fresh gas flow, rather than true EtO<sub>2</sub> [<a href="#rid20">20</a>]. The SaO<sub>2</sub> may also be a misleading guide to the efficacy of preoxygenation. A SaO<sub>2</sub> of 100 percent may occur well before the lungs are adequately denitrogenated. Conversely, failure of SaO<sub>2</sub> to increase substantially during preoxygenation does not necessarily indicate failure of the technique; patients with substantial extrapulmonary shunting may achieve excellent pulmonary oxygen reservoirs while remaining hypoxemic [<a href="#rid21">21</a>].</p><p>The process of oxygen wash in and nitrogen wash out is an exponential function. As with all exponential functions the rate of this process is governed by a time constant (t). In this case, t is proportional to the functional residual capacity (FRC) and inversely proportional to alveolar ventilation (VA). The time required for preoxygenation will depend on the size of the FRC (the larger the FRC the longer time required for full preoxygenation) and the VA (increasing alveolar ventilation reduces the time needed for preoxygenation). </p><div class="formulaContainer"><div class="formula"><p><em>T</em> ∝ FRC/V<sub>A</sub> </p></div></div><p>After 1T the oxygen concentration will be increased by approximately 63 percent of its original value; 86 percent after 2T; 93 percent after 3T; and to 98 percent after 4T [<a href="#rid22">22</a>].</p><p>The anesthesia circuit is a reservoir from which nitrogen must be removed or washed out. This is also an exponential function with the time constant dependent on the size of the circuit and oxygen flow [<a href="#rid23">23,24</a>]. Therefore, flushing with oxygen before attempting preoxygenation and selecting a flow rate of oxygen that eliminates rebreathing will minimize the time required to preoxygenate. The fraction of inspired oxygen (FiO<sub>2</sub>) is influenced by the type of breathing, the duration of breathing, and the level of fresh gas flow [<a href="#rid25">25</a>]. (See <a class="local">'Maximizing FiO2'</a> below.)</p><p class="headingAnchor" id="H52738833"><span class="h2">Efficiency</span><span class="headingEndMark"> — </span>The delay in desaturation during apnea after preoxygenation (ie, efficiency), is dependent on the efficacy of preoxygenation, the capacity for oxygen loading and the rate of oxygen consumption. Thus, the factors that affect efficiency include the volume of the FRC, PaO<sub>2</sub>, the arterial oxygen content, cardiac output, and the rate of tissue oxygen consumption. Patients with reduced oxygen loading potential (primarily reduced FRC) or those with increased oxygen consumption will desaturate much faster during apnea [<a href="#rid26">26-29</a>]. The effect of FRC and oxygen consumption on the efficiency of preoxygenation is shown in a figure  (<a class="graphic graphic_figure graphicRef118559" href="/d/graphic/118559.html" rel="external">figure 2</a>). Oxygen delivery and consumption and abnormalities of these processes are discussed separately. (See  <a class="medical medical_review" href="/d/html/1623.html" rel="external">"Oxygen delivery and consumption"</a>.)</p><p class="headingAnchor" id="H1165437547"><span class="h1">PREOXYGENATION TECHNIQUES</span></p><p class="headingAnchor" id="H2935625681"><span class="h2">General principles</span><span class="headingEndMark"> — </span>Efficacy of preoxygenation can be optimized by maximizing the <strong>usable space</strong> of the lung reservoir for oxygen (ie, recruiting lung units by reducing atelectasis or consolidation) and maximizing the <strong>filling</strong> of the reservoir with oxygen (ie, using a fraction of inspired oxygen [FiO<sub>2</sub>] of 100 percent and achieving an end-tidal oxygen [EtO<sub>2</sub>] as high as possible)  (<a class="graphic graphic_figure graphicRef119612" href="/d/graphic/119612.html" rel="external">figure 1</a>). </p><p class="headingAnchor" id="H909587956"><span class="h3">Maximizing FiO2</span><span class="headingEndMark"> — </span>The main reasons for failure to achieve a fraction of inspired oxygen (FiO<sub>2</sub>) of close to 1.0 are a leak under the face mask [<a href="#rid17">17,30-33</a>], rebreathing of exhaled gases, and use of systems incapable of delivering high FiO<sub>2</sub> [<a href="#rid34">34</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevent entrainment of air </strong>– Entrainment of room air from underneath a face mask will be reduced by choosing an appropriately sized mask and applying it tightly to the face. In one study, using gravity alone to keep a face mask in place allowed &gt;20 percent entrainment of room air, with fresh gas flow of 10 L/minute [<a href="#rid33">33</a>]. The technique, including the importance of a tight fitting mask, should be explained to the patient in advance. A tight seal may be challenging in edentulous patients, those with facial hair, and those with a nasogastric tube in place. Applying a transparent occlusive dressing (eg, Tegaderm) to the beard or mustache area underneath the face mask may be helpful. Endpoints that indicate a good seal include appropriate movement of the reservoir bag during respiration, a normal capnogram and end-tidal carbon dioxide (EtCO<sub>2</sub>), and expected expired oxygen concentration [<a href="#rid17">17</a>]. Where a good mask seal cannot be obtained or a patient is claustrophobic, he/she may breathe through a mouthpiece (eg, Entonox connector) connected to the anesthesia circuit with his/her nose occluded.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Use high flow oxygen </strong>– Oxygen flow of at least 10 L/minute will prevent rebreathing of exhaled gases with most breathing circuits and assure maximal FiO<sub>2</sub> during preoxygenation. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Denitrogenate the breathing circuit</strong> – Any reservoir bags should be emptied and the circuit should be flushed with oxygen prior to commencing preoxygenation. The purpose is to denitrogenate the breathing circuit.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avoiding self-inflating resuscitation bag for preoxygenation </strong>–<strong> </strong>Self-inflating resuscitation bags have been designed for positive pressure ventilation. They have variable characteristics when used for spontaneously breathing patients and often entrain room air in this situation [<a href="#rid34">34,35</a>]. The valve type and design may also increase the work of breathing. </p><p></p><p class="headingAnchor" id="H2303262990"><span class="h3">Inspired and expired gas monitoring</span><span class="headingEndMark"> — </span>Capnography and EtO<sub>2</sub> monitoring should always be used to assess efficacy during preoxygenation (see <a class="local">'Efficacy'</a> above). An EtO<sub>2</sub> of &gt;94 percent cannot usually be achieved due to the presence of carbon dioxide and water vapor in the expired gases. Erroneously high EtO<sub>2</sub> readings can occur with small tidal volumes and reflects a sampling of the fresh gas flow or dead space gasses.</p><p class="headingAnchor" id="H1635974467"><span class="h3">Positioning</span><span class="headingEndMark"> — </span>Patients should be preoxygenated in the head up or reverse Trendelenburg position, unless they are at risk for hypotension with the head up position. The supine position reduces functional residual capacity (FRC) and increases dependent atelectasis, thereby shortening the safe apnea time, particularly in patients with obesity. (See  <a class="medical medical_review" href="/d/html/14932.html" rel="external">"Anesthesia for the patient with obesity", section on 'Preoxygenation and apneic oxygenation'</a>.) </p><p>The head up position improves the efficacy of preoxygenation and prolongs the safe apnea time when compared with the supine position, even in non-obese patients [<a href="#rid36">36-38</a>]. However, head up positioning may not increase the safe apnea time after preoxygenation in pregnant patients [<a href="#rid39">39</a>]. </p><p class="headingAnchor" id="H627212358"><span class="h2">Breathing technique for routine preoxygenation</span><span class="headingEndMark"> — </span>The breathing technique employed affects the speed and efficacy of preoxygenation. Preoxygenation is typically performed with tidal volume breathing (TVB) (ie, normal depth and rate of ventilation) for at least three minutes. For rapid preoxygenation using deeper breaths, optimal efficacy and efficiency can be achieved with eight vital capacity breaths over one minute  (<a class="graphic graphic_figure graphicRef118561" href="/d/graphic/118561.html" rel="external">figure 4</a>).</p><p class="headingAnchor" id="H3960892731"><span class="h3">Tidal volume breathing</span><span class="headingEndMark"> — </span>TVB preoxygenation requires at least three minutes for maximal denitrogenation, depending on patient factors. For a 70 kg person inhaling tidal volume breaths of approximately 490 mL (7 mL/kg), at a respiratory rate of 12 per minute, with anatomical dead space 140 mL (2 mL/kg), alveolar ventilation would be equal to 4200 mL per min. If the FRC is 3000 mL then the time constant for nitrogen wash out would be approximately 0.7 minutes, and 2.8 minutes (4 time constants) would be required to achieve 98 percent nitrogen washout. Because of interindividual variation in FRC and alveolar ventilation, preoxygenation with TVB should be performed for at least three minutes, and or optimally until the EtO<sub>2</sub> is &gt;90 percent. Preoxygenation with tidal volume breaths occurs more rapidly in pregnant patients at term and can be reduced to two minutes for maximal increase in EtO<sub>2 </sub>[<a href="#rid40">40</a>]. </p><p>Efficiency, as measured by safe apnea time after preoxygenation with TVB for three minutes, has been reported at approximately 4 to 9 minutes in normal weight, nonpregnant adults [<a href="#rid6">6,7</a>]. Efficacy with this technique has been reported at 88 to 92 percent EtO<sub>2</sub> [<a href="#rid25">25,41,42</a>].</p><p class="headingAnchor" id="H932093383"><span class="h3">Deep breathing techniques</span><span class="headingEndMark"> — </span>Preoxygenation techniques using vital capacity breaths were introduced to reduce the time required for efficacious preoxygenation. The increased minute ventilation achieved by deep breathing theoretically reduces the time constant for nitrogen washout and therefore increases the speed of preoxygenation. </p><p>Most studies have reported that preoxygenation with eight vital capacity breaths over the course of one minute is equally effective and efficient as three minutes of TVB, and that both techniques are superior to preoxygenation with four deep breaths over 30 seconds, including in older adult patients [<a href="#rid1">1,7,16,25,41-43</a>]. In one study, preoxygenation with eight deep breaths over one minute slowed the fall in oxygen saturation during apnea compared with both TVB and four deep breaths over 30 seconds  (<a class="graphic graphic_figure graphicRef118561" href="/d/graphic/118561.html" rel="external">figure 4</a>) [<a href="#rid16">16</a>]. Extending deep breathing to 1.5 or 2 minutes may further increase the likelihood of achieving an ETO<sub>2</sub> &gt;90 percent [<a href="#rid25">25</a>]. </p><p class="headingAnchor" id="H4069506771"><span class="h3">Prior maximal exhalation</span><span class="headingEndMark"> — </span>Maximal exhalation before preoxygenation with either deep breathing or TVB confers no additional benefit. Maximal exhalation results in a more rapid rise in ETO<sub>2</sub> in the first minute of preoxygenation, but does not affect the time required to reach ETO<sub>2</sub> &gt;90 percent [<a href="#rid44">44</a>].</p><p class="headingAnchor" id="H3194641538"><span class="h2">Positive airway pressure techniques during preoxygenation</span><span class="headingEndMark"> — </span>Positive airway pressure techniques used during preoxygenation and during ventilation prior to intubation increase FRC [<a href="#rid45">45</a>], reduce atelectasis [<a href="#rid46">46,47</a>] and intrapulmonary shunting, and increase the safe apnea time. Options include continuous positive airway pressure (CPAP), positive end-expiratory pressure (PEEP), bilevel positive airway pressure (BPAP), and noninvasive positive pressure ventilation. (See <a class="local">'High-risk patients'</a> below.)</p><p>During preoxygenation PEEP is most easily applied by closing the adjustable pressure limiting (APL) valve on the anesthetic circuit and maintaining a tight face mask seal as the patient breathes spontaneously. After induction of anesthesia and prior to intubation, CPAP can be achieved by maintaining an open airway with PEEP during positive pressure mask ventilation.  </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy with positive airway pressure techniques </strong>–<strong> </strong>The efficacy of preoxygenation is increased when using positive airway pressure techniques. Preoxygenation utilizing noninvasive ventilation (NIV) or CPAP has been shown to increase the proportion of patients attaining the preoxygenation target of ETO<sub>2</sub> &gt;90 percent in both obese and non-obese subjects [<a href="#rid48">48</a>]. NIV can also reduce time required to complete preoxygenation [<a href="#rid49">49</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficiency with positive airway pressure techniques </strong>–<strong> </strong>The use of CPAP during preoxygenation prior to induction of anesthesia has been shown to increase the safe apnea time in non-obese individuals [<a href="#rid50">50,51</a>]. For patients with obesity, the effect of positive pressure ventilation during preoxygenation may depend on the duration and level of positive pressure. In one study of patients with severe obesity who underwent rapid sequence induction and intubation (RSII), there was no difference in the time to desaturation to 90 percent in patients who were preoxygenated for three minutes with CPAP at 7.5 cm H<sub>2</sub>O, compared with patients without CPAP [<a href="#rid52">52</a>]. In contrast, in another trial that included 30 patients with severe obesity, preoxygenation with PEEP of 10 cm H<sub>2</sub>O, followed by mask ventilation with PEEP at 10 cm H<sub>2</sub>O for another five minutes until intubation increased the safe apnea time by 50 percent (from 127 to 188 seconds) [<a href="#rid53">53</a>].</p><p></p><p>NIV for preoxygenation, with [<a href="#rid54">54</a>] or without [<a href="#rid55">55</a>] the use of high flow nasal cannulae, may reduce the incidence of severe oxygen desaturation during intubation of critically ill patients in the intensive care unit (ICU). (See  <a class="medical medical_review" href="/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care", section on 'Right-to-left intrapulmonary shunting'</a>.)</p><p>High flow nasal oxygen provides positive airway pressure along with apneic oxygenation. (See  <a class="medical medical_review" href="/d/html/114077.html" rel="external">"Heated and humidified high-flow nasal oxygen in adults: Practical considerations and potential applications", section on 'General principles of application'</a> and <a class="local">'Heated humidified high flow nasal oxygen'</a> below.)</p><p class="headingAnchor" id="H2565360320"><span class="h2">Complications of preoxygenation</span><span class="headingEndMark"> — </span>The most important potential complication of preoxygenation is resorption atelectasis. When breathing room air, alveoli contain a high concentration of nitrogen, which is poorly soluble in blood and remains largely in the alveoli, helping to stent them open. After preoxygenation (ie, denitrogenation), absorption of oxygen from alveoli into blood accentuates the atelectasis that results from general anesthesia, and shunting can occur. (See  <a class="medical medical_review" href="/d/html/1622.html" rel="external">"Adverse effects of supplemental oxygen", section on 'Absorptive atelectasis'</a>.) </p><p>Decreasing the FiO<sub>2</sub> during preoxygenation to 0.8 prevents atelectasis formation during general anesthesia [<a href="#rid56">56</a>], but it reduces the duration of safe apnea. In a study of women who were preoxygenated for general anesthesia, preoxygenation with FiO<sub>2</sub> of 0.8 desaturated to 90 percent in a mean of 303 seconds, compared with 411 seconds in patients who were preoxygenated with 100 percent oxygen [<a href="#rid57">57</a>]. The relative risk of atelectasis versus the risk of decreasing the safe apnea time must be assessed by the clinician. The use of CPAP or PEEP can offset the occurrence of atelectasis. (See <a class="local">'Positive airway pressure techniques during preoxygenation'</a> above.)</p><p>Since preoxygenation increases the safe apnea time, desaturation will be a late sign of airway compromise, including after esophageal intubation. Therefore, EtCO<sub>2</sub> monitoring and clinical assessment of ventilation are mandatory after intubation and extubation.</p><p>Oxygen toxicity can occur after administration of supplemental oxygen; there is not a well-defined FiO<sub>2</sub> or duration of exposure below which oxygen toxicity does not occur (see  <a class="medical medical_review" href="/d/html/1622.html" rel="external">"Adverse effects of supplemental oxygen", section on 'Lung parenchymal injury'</a>). Nonetheless, given the short duration of administration of oxygen for preoxygenation and apneic oxygenation for intubation, the unknown but likely very small risk of oxygen toxicity is probably far outweighed by the risk of hypoxemia that can suddenly develop when apnea occurs. For patients who have received <a class="drug drug_general" data-topicid="9160" href="/d/drug information/9160.html" rel="external">bleomycin</a>, prolonged administration of oxygen, as might occur during apneic oxygenation for laryngeal surgery, should probably be avoided. (See  <a class="medical medical_review" href="/d/html/1622.html" rel="external">"Adverse effects of supplemental oxygen", section on 'Lung parenchymal injury'</a>.)  </p><p>Use of positive airway pressure techniques during preoxygenation could theoretically insufflate air into the stomach and increase the risk of regurgitation and aspiration, though there is no evidence that this occurs. There is no reason to avoid PEEP or NIV during preoxygenation prior to RSII for anesthesia. In a randomized study of the use of NIV for preoxygenation for intubation in critically ill patients, there were no differences in regurgitation or new infiltrates on chest radiograph after intubation in patients who were preoxygenated with NIV, compared with patients with preoxygenation by face mask [<a href="#rid55">55</a>]. Positive pressure ventilation during RSII is discussed separately. (See  <a class="medical medical_review" href="/d/html/94214.html" rel="external">"Rapid sequence induction and intubation (RSII) for anesthesia", section on 'Mask ventilation'</a>.)</p><p class="headingAnchor" id="H3409703469"><span class="h1">APNEIC OXYGENATION</span><span class="headingEndMark"> — </span>Apneic oxygenation is a process by which oxygen moves by mass flow through the upper airways and into the alveoli in the absence of any respiratory effort. A pressure gradient is created by the differential rates of oxygen removal from and carbon dioxide diffusion into the lungs [<a href="#rid58">58</a>] (see <a class="local">'Physiology of apnea'</a> above). Apneic oxygenation during intubation may be particularly beneficial in patients who are at risk for rapid desaturation, and in patients for whom airway management may be difficult or prolonged. Apneic oxygenation techniques may also be used during upper airway surgery, to allow the surgeon access to airway structures unimpeded by the presence of an endotracheal tube or supraglottic airway. </p><p class="headingAnchor" id="H3372251547"><span class="h2">Efficacy and efficiency of apneic oxygenation</span><span class="headingEndMark"> — </span>The use of apneic oxygenation has become more widespread over the past decade. Studies have demonstrated its ability to reduce the incidence of critical desaturation in a variety of clinical settings [<a href="#rid59">59-61</a>]. As an example, a meta-analysis of eight randomized and observational studies (1837 patients) of intubation in the emergency department or intensive care unit (ICU) found that apneic oxygenation was associated with reduced odds of peri-intubation desaturation to peripheral arterial oxygen saturation (SpO<sub>2</sub>) &lt;93 percent (OR 0.66, 95% CI 0.52 to 0.85) and an increase in first-pass intubation success (OR 1.59, 95% CI 1.04 to 2.44) [<a href="#rid62">62</a>]. In the included studies, apneic oxygenation was performed with either a humidified high flow nasal oxygenation system or standard nasal cannulae (see <a class="local">'Apneic oxygenation with standard nasal cannulae'</a> below and <a class="local">'Heated humidified high flow nasal oxygen'</a> below). Two other meta-analyses published in 2017, including many of the same studies, reached similar conclusions [<a href="#rid63">63,64</a>]. </p><p>Apneic oxygenation depends on maintaining a patent air passage between the lungs and oropharyngeal airspaces, and a continuous supply of oxygen to the nasopharyngeal and oropharyngeal reservoirs. Apneic oxygenation after preoxygenation can maintain arterial oxygen saturation (SaO<sub>2</sub>) for a surprising length of time; SaO<sub>2</sub> has been maintained at over 90 percent for 100 minutes in some studies [<a href="#rid65">65,66</a>]. </p><p>Optimal efficiency of apneic oxygenation requires maximal preoxygenation and delivery of 100 percent oxygen [<a href="#rid67">67</a>]. Computational modelling has shown that increasing the ambient oxygen fraction during apneic oxygenation from 0.9 to 1.0 more than doubles the time to desaturation compared with increasing the ambient oxygen fraction from 0.21 to 0.9  (<a class="graphic graphic_figure graphicRef118583" href="/d/graphic/118583.html" rel="external">figure 5</a>) [<a href="#rid67">67</a>].   </p><p>The efficiency of apneic oxygenation is also affected by the ratio of functional residual capacity (FRC) to body weight [<a href="#rid66">66</a>]. Patients with a low FRC to bodyweight ratio (eg, patients with obesity) may therefore desaturate quickly, even during apneic oxygenation. </p><p class="headingAnchor" id="H352850307"><span class="h2">Apneic oxygenation techniques</span><span class="headingEndMark"> — </span>Administration of oxygen via face mask provides minimal oxygen to apneic patients [<a href="#rid68">68</a>], and of course the mask must be removed for intubation. A variety of devices and techniques have therefore been developed to insufflate oxygen into the pharynx or trachea during intubation. Some devices that have been used for apneic oxygenation during intubation in children are shown in a figure  (<a class="graphic graphic_picture graphicRef117387" href="/d/graphic/117387.html" rel="external">picture 1</a>). Most of these devices have been used in adults as well.</p><p>The mechanisms and dynamics of oxygen flow when using apneic oxygenation techniques are the subject of continuing research. The location of delivery of oxygen insufflation and the flow rate will influence upper airway pressure, turbulence, and entrainment. The optimal location for delivery of oxygen into the airway (ie, tracheal, pharyngeal, or nasal) for apneic oxygenation has not been established. With respect to increasing the safety of airway management, the most beneficial methods of oxygen administration are those that can be started before airway manipulation, namely supplementary nasal oxygenation at low or high flows. Use of high flow nasal oxygen for preoxygenation and apneic oxygenation is discussed below. (See <a class="local">'Heated humidified high flow nasal oxygen'</a> below.)</p><p class="headingAnchor" id="H3438163182"><span class="h3">Apneic oxygenation with nasopharyngeal catheter</span><span class="headingEndMark"> — </span>Several small trials have reported prolongation of safe apnea time with administration of oxygen at 3 to 5 L/minute directly into the pharynx via a nasopharyngeal airway after preoxygenation. </p><p class="bulletIndent1"><span class="glyph">●</span>In one study of 30 patients who were preoxygenated with four deep breaths of oxygen before induction of anesthesia, patients who were randomly assigned to receive oxygen at 5 L/minute via a nasopharyngeal catheter after induction remained at SpO<sub>2</sub> 100 percent during six minutes of apnea, while patients who received no nasopharyngeal oxygen desaturated to 95 percent at a mean of 3.65 minutes [<a href="#rid69">69</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study, SpO<sub>2</sub> remained unchanged at 99 percent during 10 minutes of apnea in patients who received nasopharyngeal oxygen at 3 L/minute after preoxygenation, whereas the SpO<sub>2</sub> fell to 92 percent over approximately 7 minutes in patients who received no nasopharyngeal oxygen [<a href="#rid70">70</a>].  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial including 34 patients with severe obesity reported that SpO<sub>2</sub> was maintained at 100 percent during four minutes of apnea in 16 of 17 patients who received nasopharyngeal oxygen at 5 L/minute after preoxygenation, while SpO<sub>2</sub> fell to 95 percent in all patients who received no nasopharyngeal oxygen over a mean of 145 seconds [<a href="#rid71">71</a>].</p><p></p><p class="headingAnchor" id="H1999381586"><span class="h3">Apneic oxygenation with standard nasal cannulae</span><span class="headingEndMark"> — </span>A commonly used and readily available technique for apneic oxygenation involves the use of standard nasal cannulae. The patient is typically preoxygenated using nasal cannulae simultaneously with face mask oxygen, with nasal oxygen continued during intubation after the facemask is removed. Nasal oxygen is discontinued once the airway is secured. </p><p>Nasal oxygen during efforts at securing a tube (NO DESAT) was initially described for intubation in the emergency department [<a href="#rid72">72</a>]. Nasal oxygen flow rates up to 15 L/minute have been studied.</p><p>Apneic oxygenation with standard nasal cannula was used in a small randomized trial involving patients with severe obesity. Thirty patients were randomly assigned to receive 5 L/minute of oxygen via nasal prongs, or no oxygen via nasal prongs, during preoxygenation to end-tidal oxygen (EtO<sub>2</sub>) &gt;90 percent, and during apnea during simulated difficult intubation [<a href="#rid60">60</a>]. The time to desaturation to SpO<sub>2</sub> 95 percent was greater in patients who received nasal oxygen (mean 5.29 versus 3.49 minutes), and the minimum SpO<sub>2</sub> during apnea was higher in patients who received nasal oxygen (94.3 versus 87.7 percent). </p><p>Apneic oxygenation using nasal cannulae has not been shown to be of benefit during intubation in critically ill patients. As an example, in a randomized trial involving 150 critically ill patients who required intubation, there were no differences in the lowest SpO<sub>2</sub> or desaturation to &lt;90 percent in patients who received 15 L/minute nasal oxygen during intubation and those who received no nasal oxygen [<a href="#rid73">73</a>]. </p><p class="headingAnchor" id="H3407326246"><span class="h2">Complications of apneic oxygenation</span><span class="headingEndMark"> — </span>Carbon dioxide is not removed during apneic oxygenation and there is a consequential decrease in pH. If left unchecked cardiac arrest will ensue. The rate of rise of carbon dioxide has been shown to be approximately 3 to 4 mmHg per minute [<a href="#rid14">14</a>]. Therefore the safe limit of apneic oxygenation is estimated to be 15 minutes [<a href="#rid66">66</a>].</p><p>Oxygen is delivered via standard nasal cannulae as a cold dry gas, which has the effect of drying the nasal and respiratory mucosa. This can cause sinus pain, mucosal dehiscence and epistaxis. Flows above 4 L/minute via nasal cannula are rarely tolerated by patients for significant lengths of time. Further studies are required to assess long term outcomes (eg, length of stay in the hospital or ICU, sinusitis, upper respiratory tract infection, pneumonia) of various methods of apneic oxygenation in comparison with nasal low flow dry oxygen. </p><p class="headingAnchor" id="H1175230268"><span class="h1">HEATED HUMIDIFIED HIGH FLOW NASAL OXYGEN</span><span class="headingEndMark"> — </span>Heated humidified high flow oxygen (HFNO; &gt;30 liters/minute) is highly effective for preoxygenation and apneic oxygenation, and has also been used as the primary airway technique for laryngeal surgery. The best available evidence suggests that HFNO does not clear carbon dioxide. </p><p>Low flow oxygen delivery devices are defined as those with which the fraction of inspired oxygen (FiO<sub>2</sub>) varies with inspiratory flow. High flow devices are capable of delivering oxygen at flow rates that match peak inspiratory flow. At these high flows, the gas must be warmed and humidified both for patient comfort and to prevent damage to airway mucosa. The benefits of heated and humidified high flow nasal oxygen (HFNO) include pharyngeal dead space washout; reduction in the work of breathing; positive end-expiratory pressure (PEEP); a constant FiO<sub>2</sub>; and improved mucociliary clearance. (See  <a class="medical medical_review" href="/d/html/114077.html" rel="external">"Heated and humidified high-flow nasal oxygen in adults: Practical considerations and potential applications", section on 'Mechanisms of clinical benefit'</a>.)</p><p>The use of apneic oxygenation (including HFNO) in children is discussed separately. (See  <a class="medical medical_review" href="/d/html/117124.html" rel="external">"Management of the difficult airway for pediatric anesthesia", section on 'Apneic oxygenation'</a>.)</p><p class="headingAnchor" id="H1481571907"><span class="h2">HFNO for preoxygenation and apneic oxygenation</span><span class="headingEndMark"> — </span>Advantages to the use of HFNO for preoxygenation and apneic oxygenation include the ability to deliver an FiO<sub>2</sub> of 100 percent without requiring a tight mask seal, and that it leaves the operator’s hands free. HFNO also allows a seamless transition from preoxygenation to apneic oxygenation and prolonged apnea time. However, HFNO cannot be performed simultaneously with face mask ventilation, so the operator cannot confirm the ability to achieve a mask seal or successfully ventilate by mask. End tidal gas sampling/capnography cannot be used with HFNO. Thus, for prolonged apneic oxygenation (ie, beyond 30 minutes) with HFNO, CO<sub>2</sub> should be monitored using transcutaneous CO<sub>2</sub>, intermittent arterial blood gases, or intermittent ventilation with measurement of EtCO<sub>2</sub>.</p><p>For preoxygenation with HFNO the initial oxygen flow rate is set to 30 L/minute. The patient is asked to take tidal volume breaths via nasal breathing, with the mouth closed [<a href="#rid74">74-76</a>] for three minutes. After induction of anesthesia, the flow rate is increased to 70 L/minute and maintained until the endotracheal tube is in place. Airway patency <strong>must</strong> be maintained via jaw thrust and an oropharyngeal airway, if necessary, while HFNO is used. </p><p>Multiple studies have found that the use of HFNO for preoxygenation and apneic oxygenation prolongs apnea time compared with face mask preoxygenation [<a href="#rid58">58,77-82</a>]. </p><p class="headingAnchor" id="H2640987359"><span class="h2">Ventilatory exchange with HFNO</span><span class="headingEndMark"> — </span>When HFNO was initially used for apneic oxygenation during anesthesia, the term transnasal humidified rapid insufflation ventilatory exchange (THRIVE) was used. However, HFNO has not consistently been shown to slow the rate of rise of CO<sub>2</sub> compared with low flow apneic oxygenation techniques. Some studies have reported reduced rate of rise of CO<sub>2</sub> during apneic oxygenation with HFNO [<a href="#rid58">58,77,83-86</a>], while others have found no difference [<a href="#rid87">87-89</a>]. </p><p>A single center trial assessed the rate of rise of CO<sub>2</sub> in 125 heathy surgical patients who were randomly assigned to receive apneic oxygenation at one of four oxygen flows after induction of anesthesia and paralysis (0.25 L/minute, 2 L/minute, 10 L/minute, 70 L/minute with jaw thrust, 70 L/minute with continuous video laryngoscopy) [<a href="#rid89">89</a>]. The rate of rise of CO<sub>2</sub> assessed by arterial blood gases every 2 minutes was similar across all groups and did not reach a predefined noninferiority threshold. In addition, the rate of oxygen desaturation over the 15-minute apneic period was similar across all groups. </p><p class="headingAnchor" id="H1962691435"><span class="h2">Utility for special patient populations</span><span class="headingEndMark"> — </span>Many studies have quantified the utility of HFNO for surgical anesthesia, and in different patient groups including those with severe obesity. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emergency intubation –</strong> Several studies suggest that HFNO may be beneficial for preoxygenation and apneic oxygenation for emergency intubation. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a small randomized trial that compared face mask preoxygenation with preoxygenation with HFNO for patients who underwent rapid sequence induction and intubation (RSII), there were no differences in arterial partial pressure of oxygen (PaO<sub>2</sub>) or arterial partial pressure of carbon dioxide (PaCO<sub>2</sub>)<sub> </sub>immediately after intubation, despite a significantly longer apnea time in the patients who were managed with HFNO (248 versus 123 seconds) [<a href="#rid78">78</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In another trial, 80 adults who underwent rapid sequence induction and intubation (RSII) for emergency surgery were randomly assigned to face mask preoxygenation or HFNO for preoxygenation and apneic oxygenation until intubation [<a href="#rid79">79</a>]. There were no differences in median lowest peripheral arterial oxygen saturation (SpO<sub>2</sub>) until one minute after intubation, but five patients who received face mask preoxygenation desaturated to &lt;93 percent, compared with none in the HFNO group. There were no episodes of aspiration or regurgitation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a larger international randomized trial comparing HFNO for preoxygenation and apneic oxygenation with face mask preoxygenation for RSII in 350 patients who had emergency surgery, the number of patients who desaturated to SpO<sub>2</sub> &lt;93 percent was similar in the two groups (five [2.9 percent] versus six [3.4 percent]) patients in the high-flow nasal oxygen and facemask group, respectively [<a href="#rid80">80</a>]. Although mean apnea time was longer in the HFNO group, first breath ETCO<sub>2 </sub>was similar. This study demonstrates the feasibility of using HFNO as a primary means of preoxygenation in patients undergoing RSII. </p><p></p><p class="bulletIndent1">Computed tomography assessment of gastric volume has shown that HFNO preoxygenation does not increase gastric volume as compared with traditional face mask preoxygenation and is unlikely to increase the risk of aspiration [<a href="#rid90">90</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Severe obesity – </strong>In one trial, 40 patients with severe obesity (body mass index [BMI] &gt;40 kg/m<sup>2</sup>) who underwent general anesthesia for surgery were randomly assigned to preoxygenation and apneic oxygenation with HFNO, vs three minutes of conventional face mask preoxygenation [<a href="#rid81">81</a>]. Safe apnea time was longer (261.4 ± 77.7 vs 185.5 ± 52.9 seconds) and the minimum peri-intubation SpO<sub>2</sub> was higher (91.0 ± 3.5 vs 88.0 ± 4.8 percent) in the high-flow nasal oxygenation group.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Elderly patients – </strong>In a<strong> </strong>randomized trial including 60 patients aged 65 to 80yrs without known pulmonary disease who underwent general anesthesia, safe apnea time was prolonged with the use of HFNO compared with face mask oxygenation, when either technique was used for preoxygenation and apneic oxygenation [<a href="#rid82">82</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy – </strong>Preoxygenation and apneic oxygenation in pregnant patients is discussed separately. (See  <a class="medical medical_review" href="/d/html/16690.html" rel="external">"Airway management for the pregnant patient"</a>.) </p><p></p><p>HFNO for preoxygenation before intubation in the intensive care unit (ICU) is discussed separately. (See  <a class="medical medical_review" href="/d/html/114077.html" rel="external">"Heated and humidified high-flow nasal oxygen in adults: Practical considerations and potential applications", section on 'Intubation support'</a>.)</p><p class="headingAnchor" id="H148570595"><span class="h2">HFNO for laryngologic surgery</span><span class="headingEndMark"> — </span>HFNO may be used for apneic ventilation during laryngologic surgery that requires ventilation without an airway device in place. In this setting, HFNO is typically used for preoxygenation at a flow rate of 30 L/minute. After induction of anesthesia, HFNO is temporarily stopped to confirm the ability to ventilate by face mask. HFNO is then restarted at 70 L/minute and airway patency must be meticulously maintained until the surgical laryngoscope is inserted. </p><p>The maximum recommended duration of HFNO is 30 minutes unless PaCO<sub>2</sub> is measured. Since capnography is not possible while HFNO is in progress, transcutaneous carbon dioxide monitoring should be used where available, or arterial blood gases should be measured. If either of these modalities are not available and surgery needs to continue for longer than 30 minutes HFNO may be paused intermittently and EtCO<sub>2</sub> measured. This technique should be avoided in patients at risk of sequelae from hypercapnia (eg, brain injury, pulmonary hypertension). </p><p>Examples of studies of the use of HFNO for airway management during general anesthesia include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>In a landmark study, 25 patients who had general anesthesia were preoxygenated with a HFNO system at 70 L/min, which was continued for apneic oxygenation [<a href="#rid58">58</a>]. The patients underwent a variety of surgical procedures, including laryngologic surgery, which required different methods for definitive airway management. No patient desaturated to &lt;90 percent SpO<sub>2</sub> during apneic periods lasting 5 to 65 minutes. The rate of rise of EtCO<sub>2</sub> was 1.13 mmHg (or 0.15 kPa) per minute, lower than reported rates of 3 to 4.2 mmHg/minute with classic apneic oxygenation [<a href="#rid14">14,65,66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In an observational study of 30 patients who underwent laryngologic surgery using HFNO with oxygen at 70 L/minute for up to 30 minutes of apnea, no patient had an SpO<sub>2</sub> &lt;91 percent [<a href="#rid85">85</a>]. PaCO<sub>2</sub> rose at 1.8 mmHg/minute. In one patient, jet ventilation was started when the PaCO<sub>2</sub> reached 82.5 mmHg. </p><p></p><p class="headingAnchor" id="H3656695267"><span class="h2">Use of HFNO in patients with COVID-19</span><span class="headingEndMark"> — </span>Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, is thought to occur primarily through respiratory droplets and aerosols. Thus, there has been concern that use of HFNO may increase transmission of COVID-19. However, simulator studies using smoke have found that the dispersal distance using HFNO is similar to or less than other oxygen delivery devices including face mask, venturi masks, and non-rebreathing masks [<a href="#rid91">91,92</a>]. In addition, in a randomized control trial in critically ill patients with bacterial pneumonia, HFNO was not associated with increased environmental bacterial contamination, compared with a conventional oxygen mask [<a href="#rid93">93</a>]. Based on these findings, use of HFNO for anesthesia is unlikely to increase the risk of infectious contamination of the environment compared with other oxygenation techniques. Nonetheless, appropriate personal protective equipment should always be used when managing the airway in patients with COVID-19. Airway management in patients with COVID-19 and use of HFNO in COVID-19 patients in the ICU are discussed separately. (See  <a class="medical medical_review" href="/d/html/127481.html" rel="external">"COVID-19: Perioperative risk assessment, preoperative screening and testing, and timing of surgery after infection"</a> and  <a class="medical medical_review" href="/d/html/131226.html" rel="external">"COVID-19: Respiratory care of the nonintubated hypoxemic adult (supplemental oxygen, noninvasive ventilation, and intubation)", section on 'Noninvasive modalities'</a>.)</p><p class="headingAnchor" id="H515733056"><span class="h1">OUR STRATEGIES FOR PREOXYGENATION AND APNEIC OXYGENATION</span><span class="headingEndMark"> — </span>All patients should be preoxygenated prior to induction of general anesthesia. The technique chosen and the decision to use apneic oxygenation should be individualized, based on patient and clinical factors, and availability of resources and equipment. The choice of awake intubation rather than airway management after induction of anesthesia for patients with predicted difficult airways is discussed separately. (See  <a class="medical medical_review" href="/d/html/90615.html" rel="external">"Management of the difficult airway for general anesthesia in adults", section on 'Timing of airway control'</a>.)</p><p>Our approach to preoxygenation and apneic oxygenation is as follows:</p><p class="headingAnchor" id="H3022199128"><span class="h2">Routine preoxygenation</span><span class="headingEndMark"> — </span>For patients without risk factors for difficulty with airway management or rapid oxygen desaturation with apnea, we position the patients head up, and administer 100 percent oxygen via a tight fitting face mask for at least three minutes of tidal volume breathing (TVB; ie, normal depth and rate of respiration), or to an end-tidal oxygen concentration (EtO<sub>2</sub>) of ≥90 percent, prior to induction of anesthesia. (See <a class="local">'Positioning'</a> above and <a class="local">'Tidal volume breathing'</a> above.) </p><p>After induction of anesthesia and before a definitive airway is inserted we apply positive end-expiratory pressure (PEEP) at approximately 5 cm H<sub>2</sub>O using the adjustable pressure limiting (APL) valve. (See <a class="local">'Positive airway pressure techniques during preoxygenation'</a> above.) </p><p class="headingAnchor" id="H1293950198"><span class="h2">Preoxygenation for emergency intubation</span><span class="headingEndMark"> — </span>For emergency intubation in patients without risk factors for difficulty with airway management or rapid desaturation with apnea: </p><p class="bulletIndent1"><span class="glyph">●</span>Position the patient head up unless the patient is hypovolemic. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Whenever possible, administer 100 percent oxygen at 10 to 12 L/minute via tight fitting face mask, and ask the patient to take eight maximal breaths over one minute prior to induction of anesthesia. (See <a class="local">'Deep breathing techniques'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Apply PEEP of approximately 5 cm H<sub>2</sub>O during preoxygenation by tightening the APL valve on the anesthesia circuit. (See <a class="local">'Positive airway pressure techniques during preoxygenation'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After induction of anesthesia, use apneic oxygenation, maintain PEEP at 5 cm H<sub>2</sub>O, and ventilate by mask with peak pressures &lt;20 cm H<sub>2</sub>O, even for rapid sequence induction and intubation (RSII). (See <a class="local">'Apneic oxygenation'</a> above.)  </p><p></p><p class="headingAnchor" id="H705142648"><span class="h2">High-risk patients</span><span class="headingEndMark"> — </span>High-risk patients include those with anticipated difficulty with airway management, reduced functional residual capacity (FRC), increased oxygen consumption, and medical conditions with reduced oxygenation  (<a class="graphic graphic_table graphicRef120162" href="/d/graphic/120162.html" rel="external">table 2</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>Position the patient head up if the patient is hemodynamically stable. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For hypoxic patients, use noninvasive ventilation for preoxygenation if time permits, and use apneic oxygenation after induction of anesthesia. (See  <a class="medical medical_review" href="/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients who are not hypoxic preoperatively, we prefer high flow nasal oxygen (HFNO) for preoxygenation and for apneic oxygenation after induction of anesthesia. We set the flow rate at 30 L/minute for preoxygenation, and turn it up to 70 L/minute after induction of anesthesia. (See <a class="local">'HFNO for preoxygenation and apneic oxygenation'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If equipment for HFNO is unavailable and for emergency intubation in high-risk patients, administer oxygen via nasal cannulae at 15 L/minute in addition to oxygen at 10 to 12 L/minute via tight fitting face mask with PEEP at approximately 5 cm H<sub>2</sub>O for preoxygenation (see <a class="local">'Apneic oxygenation with standard nasal cannulae'</a> above). We provide low pressure (&lt;20 cm H<sub>2</sub>O) mask ventilation after induction and before intubation. </p><p></p><p class="headingAnchor" id="H2113003372"><span class="h2">Preoxygenation for laryngeal surgery</span><span class="headingEndMark"> — </span>For laryngeal surgery that requires ventilation without an airway device in place, we select a preoxygenation technique according to the plan for intraoperative ventilation. </p><p class="bulletIndent1"><span class="glyph">●</span>If jet ventilation is used, we perform routine preoxygenation as described above, depending on patient factors.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If HFNO will be used for apneic ventilation during surgery, we preoxygenate with HFNO at 30 L/minute, and turn the flow up to 70 L/minute after induction of anesthesia. (See <a class="local">'HFNO for laryngologic surgery'</a> above.), </p><p></p><p class="headingAnchor" id="H3728238083"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/127884.html" rel="external">"Society guideline links: Airway management in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/126613.html" rel="external">"Society guideline links: COVID-19 – Index of guideline topics"</a>.)</p><p class="headingAnchor" id="H3186166737"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Effective preoxygenation will increase the total body stores of oxygen, primarily in the lungs, and thereby lengthen the time until depletion occurs during apnea  (<a class="graphic graphic_table graphicRef119561" href="/d/graphic/119561.html" rel="external">table 1</a>). (See <a class="local">'Oxygen storage'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The end-tidal oxygen concentration (EtO<sub>2</sub>) is used to assess efficacy, with an EtO<sub>2</sub> of 90 percent considered an adequate target. Efficacy can be optimized by recruiting lung space as a reservoir for oxygen (eg, with head up positioning, use of positive end-expiratory pressure [PEEP]), and maximizing the fraction of inspired oxygen (FiO<sub>2</sub>; eg, by using oxygen flow ≥10 L/minute and maintaining a tight mask seal)  (<a class="graphic graphic_table graphicRef119561" href="/d/graphic/119561.html" rel="external">table 1</a> and <a class="graphic graphic_figure graphicRef119612" href="/d/graphic/119612.html" rel="external">figure 1</a>). (See <a class="local">'Efficacy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The efficiency of preoxygenation (ie, the delay in desaturation during apnea) is affected by patient factors, primarily the volume of the functional residual capacity (FRC) and rate of oxygen consumption, as well as the efficacy of preoxygenation  (<a class="graphic graphic_figure graphicRef118559" href="/d/graphic/118559.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef118583" href="/d/graphic/118583.html" rel="external">figure 5</a>). (See <a class="local">'Efficiency'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preoxygenation is performed with tidal volume breathing (TVB) for at least three minutes, or with eight vital capacity breaths over one minute  (<a class="graphic graphic_figure graphicRef118561" href="/d/graphic/118561.html" rel="external">figure 4</a>). (See <a class="local">'Breathing technique for routine preoxygenation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Positive pressure techniques (ie, PEEP, continuous positive airway pressure [CPAP], bilevel positive airway pressure [BPAP]) during preoxygenation increases the safe apnea time. (See <a class="local">'Positive airway pressure techniques during preoxygenation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Apneic oxygenation prolongs the safe apnea time during attempts at airway management and can be used during airway surgery without the presence of an airway device. Options for low flow apneic oxygenation include standard nasal cannulae, and nasopharyngeal catheters. (See <a class="local">'Apneic oxygenation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>High flow nasal oxygen (HFNO) can be used for preoxygenation, and for oxygenation and ventilation during laryngologic surgery. The rate of rise of CO<sub>2</sub> during HFNO is unpredictable. Therefore, for prolonged apneic oxygenation (ie, beyond 30 minutes) with HFNO, CO<sub>2</sub> should be monitored using transcutaneous CO<sub>2</sub>, intermittent arterial blood gases, or intermittent ventilation with measurement of EtCO<sub>2</sub>. (See <a class="local">'Heated humidified high flow nasal oxygen'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For routine preoxygenation, we position patients head up, administer 100 percent oxygen via a tight fitting face mask for at least three minutes of TVB, or to an peripheral arterial oxygen saturation (SpO<sub>2</sub>) of &gt;90 percent, and we use PEEP during ventilation after induction of anesthesia. (See <a class="local">'Routine preoxygenation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For preoxygenation for emergency intubation in patients without risk factors for difficulty with airway management or rapid desaturation with apnea  (<a class="graphic graphic_table graphicRef120162" href="/d/graphic/120162.html" rel="external">table 2</a>), we position hemodynamically stable patients head up, and administer 100 percent oxygen with PEEP at 5 cm H<sub>2</sub>O via a tight fitting face mask during 8 maximal breaths over one minute. We ventilate by mask with peak pressures &lt;20 cm H<sub>2</sub>O after induction and prior to intubation. (See <a class="local">'Preoxygenation for emergency intubation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with risk factors for rapid desaturation or anticipated difficulty with airway management, we position hemodynamically stable patients head up. For hypoxic patients, we use noninvasive ventilation (NIV) for preoxygenation and use apneic oxygenation after induction of anesthesia. For patients who are not hypoxic, we prefer to use HFNO for preoxygenation and apneic oxygenation after induction of anesthesia, or nasal cannulae in addition to face mask oxygen if HFNO is unavailable and ventilate by mask with peak pressures &lt;20 cm H<sub>2</sub>O after induction and prior to intubation. (See <a class="local">'High-risk patients'</a> above.)</p><p></p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Valentine SJ, Marjot R, Monk CR. Preoxygenation in the elderly: a comparison of the four-maximal-breath and three-minute techniques. Anesth Analg 1990; 71:516.</a></li><li><a class="nounderline abstract_t">Berry CB, Myles PS. Preoxygenation in healthy volunteers: a graph of oxygen "washin" using end-tidal oxygraphy. Br J Anaesth 1994; 72:116.</a></li><li><a class="nounderline abstract_t">Bhatia PK, Bhandari SC, Tulsiani KL, Kumar Y. End-tidal oxygraphy and safe duration of apnoea in young adults and elderly patients. Anaesthesia 1997; 52:175.</a></li><li><a class="nounderline abstract_t">BARTLETT RG Jr, BRUBACH HF, SPECHT H. Demonstration of aventilatory mass flow during ventilation and apnea in man. J Appl Physiol 1959; 14:97.</a></li><li><a class="nounderline abstract_t">Mort TC. The incidence and risk factors for cardiac arrest during emergency tracheal intubation: a justification for incorporating the ASA Guidelines in the remote location. J Clin Anesth 2004; 16:508.</a></li><li><a class="nounderline abstract_t">Baraka A. Routine pre-oxygenation. Anaesthesia 2006; 61:612.</a></li><li><a class="nounderline abstract_t">Gambee AM, Hertzka RE, Fisher DM. Preoxygenation techniques: comparison of three minutes and four breaths. Anesth Analg 1987; 66:468.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 2003; 98:1269.</a></li><li><a class="nounderline abstract_t">Bell MD. Routine pre-oxygenation - a new 'minimum standard' of care? Anaesthesia 2004; 59:943.</a></li><li><a class="nounderline abstract_t">Kung MC, Hung CT, Ng KP, et al. Arterial desaturation during induction in healthy adults: should preoxygenation be a routine? Anaesth Intensive Care 1991; 19:192.</a></li><li><a class="nounderline abstract_t">Difficult Airway Society Extubation Guidelines Group, Popat M, Mitchell V, et al. Difficult Airway Society Guidelines for the management of tracheal extubation. Anaesthesia 2012; 67:318.</a></li><li class="breakAll">https://www.das.uk.com/guidelines/das_intubation_guidelines.</li><li><a class="nounderline abstract_t">Schulz CM, Endsley MR, Kochs EF, et al. Situation awareness in anesthesia: concept and research. Anesthesiology 2013; 118:729.</a></li><li><a class="nounderline abstract_t">EGER EI, SEVERINGHAUS JW. The rate of rise of PaCO2 in the apneic anesthetized patient. Anesthesiology 1961; 22:419.</a></li><li><a class="nounderline abstract_t">Gold MI, Duarte I, Muravchick S. Arterial oxygenation in conscious patients after 5 minutes and after 30 seconds of oxygen breathing. Anesth Analg 1981; 60:313.</a></li><li><a class="nounderline abstract_t">Baraka AS, Taha SK, Aouad MT, et al. Preoxygenation: comparison of maximal breathing and tidal volume breathing techniques. Anesthesiology 1999; 91:612.</a></li><li><a class="nounderline abstract_t">Benumof JL. Preoxygenation: best method for both efficacy and efficiency. Anesthesiology 1999; 91:603.</a></li><li><a class="nounderline abstract_t">Archer GW Jr, Marx GF. Arterial oxygen tension during apnoea in parturient women. Br J Anaesth 1974; 46:358.</a></li><li><a class="nounderline abstract_t">Fleureaux O, Estèbe JP, Bléry C, et al. [Effects of preoxygenation methods on the course of PaO2 and PaCO2 in anesthetic post-induction apnea]. Cah Anesthesiol 1995; 43:367.</a></li><li><a class="nounderline abstract_t">Benumof JL, Herway ST. High End-Tidal Oxygen Concentration Can Be a Misleading Sole Indicator of the Completeness of Preoxygenation. Anesth Analg 2017; 124:2093.</a></li><li><a class="nounderline abstract_t">McCahon RA, Hardman JG. Fighting for breath: apnoea vs the anaesthetist. Anaesthesia 2007; 62:105.</a></li><li class="breakAll">Lumb AB. Nunn's Applied Respiratory Physiology, 7th ed, Churchill Livingstone, 2010. p.527.</li><li><a class="nounderline abstract_t">Taha SK, El-Khatib MF, Siddik-Sayyid SM, et al. Preoxygenation by 8 deep breaths in 60 seconds using the Mapleson A (Magill), the circle system, or the Mapleson D system. J Clin Anesth 2009; 21:574.</a></li><li><a class="nounderline abstract_t">Taha S, El-Khatib M, Siddik-Sayyid S, et al. Preoxygenation with the Mapleson D system requires higher oxygen flows than Mapleson A or circle systems. Can J Anaesth 2007; 54:141.</a></li><li><a class="nounderline abstract_t">Nimmagadda U, Chiravuri SD, Salem MR, et al. Preoxygenation with tidal volume and deep breathing techniques: the impact of duration of breathing and fresh gas flow. Anesth Analg 2001; 92:1337.</a></li><li><a class="nounderline abstract_t">Benumof JL, Dagg R, Benumof R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology 1997; 87:979.</a></li><li><a class="nounderline abstract_t">Farmery AD, Roe PG. A model to describe the rate of oxyhaemoglobin desaturation during apnoea. Br J Anaesth 1996; 76:284.</a></li><li><a class="nounderline abstract_t">Hayes AH, Breslin DS, Mirakhur RK, et al. Frequency of haemoglobin desaturation with the use of succinylcholine during rapid sequence induction of anaesthesia. Acta Anaesthesiol Scand 2001; 45:746.</a></li><li><a class="nounderline abstract_t">Heier T, Feiner JR, Lin J, et al. Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers. Anesthesiology 2001; 94:754.</a></li><li><a class="nounderline abstract_t">Russell GN, Smith CL, Snowdon SL, Bryson TH. Pre-oxygenation and the parturient patient. Anaesthesia 1987; 42:346.</a></li><li><a class="nounderline abstract_t">Berthoud M, Read DH, Norman J. Pre-oxygenation--how long? Anaesthesia 1983; 38:96.</a></li><li><a class="nounderline abstract_t">Drummond GB, Park GR. Arterial oxygen saturation before intubation of the trachea. An assessment of oxygenation techniques. Br J Anaesth 1984; 56:987.</a></li><li><a class="nounderline abstract_t">McGowan P, Skinner A. Preoxygenation--the importance of a good face mask seal. Br J Anaesth 1995; 75:777.</a></li><li><a class="nounderline abstract_t">Nimmagadda U, Salem MR, Joseph NJ, et al. Efficacy of preoxygenation with tidal volume breathing. Comparison of breathing systems. Anesthesiology 2000; 93:693.</a></li><li><a class="nounderline abstract_t">Mills PJ, Baptiste J, Preston J, Barnas GM. Manual resuscitators and spontaneous ventilation--an evaluation. Crit Care Med 1991; 19:1425.</a></li><li><a class="nounderline abstract_t">Lane S, Saunders D, Schofield A, et al. A prospective, randomised controlled trial comparing the efficacy of pre-oxygenation in the 20 degrees head-up vs supine position. Anaesthesia 2005; 60:1064.</a></li><li><a class="nounderline abstract_t">Ramkumar V, Umesh G, Philip FA. Preoxygenation with 20º head-up tilt provides longer duration of non-hypoxic apnea than conventional preoxygenation in non-obese healthy adults. J Anesth 2011; 25:189.</a></li><li><a class="nounderline abstract_t">Altermatt FR, Muñoz HR, Delfino AE, Cortínez LI. Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea. Br J Anaesth 2005; 95:706.</a></li><li><a class="nounderline abstract_t">Baraka AS, Hanna MT, Jabbour SI, et al. Preoxygenation of pregnant and nonpregnant women in the head-up versus supine position. Anesth Analg 1992; 75:757.</a></li><li><a class="nounderline abstract_t">McClelland SH, Bogod DG, Hardman JG. Pre-oxygenation in pregnancy: an investigation using physiological modelling. Anaesthesia 2008; 63:259.</a></li><li><a class="nounderline abstract_t">Pandit JJ, Duncan T, Robbins PA. Total oxygen uptake with two maximal breathing techniques and the tidal volume breathing technique: a physiologic study of preoxygenation. Anesthesiology 2003; 99:841.</a></li><li><a class="nounderline abstract_t">Gagnon C, Fortier LP, Donati F. When a leak is unavoidable, preoxygenation is equally ineffective with vital capacity or tidal volume breathing. Can J Anaesth 2006; 53:86.</a></li><li><a class="nounderline abstract_t">McCarthy G, Elliott P, Mirakhur RK, McLoughlin C. A comparison of different pre-oxygenation techniques in the elderly. Anaesthesia 1991; 46:824.</a></li><li><a class="nounderline abstract_t">Nimmagadda U, Salem MR, Joseph NJ, Miko I. Efficacy of preoxygenation using tidal volume and deep breathing techniques with and without prior maximal exhalation. Can J Anaesth 2007; 54:448.</a></li><li><a class="nounderline abstract_t">Futier E, Constantin JM, Petit A, et al. Positive end-expiratory pressure improves end-expiratory lung volume but not oxygenation after induction of anaesthesia. Eur J Anaesthesiol 2010; 27:508.</a></li><li><a class="nounderline abstract_t">Coussa M, Proietti S, Schnyder P, et al. Prevention of atelectasis formation during the induction of general anesthesia in morbidly obese patients. Anesth Analg 2004; 98:1491.</a></li><li><a class="nounderline abstract_t">Rusca M, Proietti S, Schnyder P, et al. Prevention of atelectasis formation during induction of general anesthesia. Anesth Analg 2003; 97:1835.</a></li><li><a class="nounderline abstract_t">Tanoubi I, Drolet P, Fortier LP, Donati F. [Inspiratory support versus spontaneous breathing during preoxygenation in healthy subjects. A randomized, double blind, cross-over trial]. Ann Fr Anesth Reanim 2010; 29:198.</a></li><li><a class="nounderline abstract_t">Delay JM, Sebbane M, Jung B, et al. The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study. Anesth Analg 2008; 107:1707.</a></li><li><a class="nounderline abstract_t">Sreejit MS, Ramkumar V. Effect of positive airway pressure during pre-oxygenation and induction of anaesthesia upon safe duration of apnoea. Indian J Anaesth 2015; 59:216.</a></li><li><a class="nounderline abstract_t">Herriger A, Frascarolo P, Spahn DR, Magnusson L. The effect of positive airway pressure during pre-oxygenation and induction of anaesthesia upon duration of non-hypoxic apnoea. Anaesthesia 2004; 59:243.</a></li><li><a class="nounderline abstract_t">Cressey DM, Berthoud MC, Reilly CS. Effectiveness of continuous positive airway pressure to enhance pre-oxygenation in morbidly obese women. Anaesthesia 2001; 56:680.</a></li><li><a class="nounderline abstract_t">Gander S, Frascarolo P, Suter M, et al. Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients. Anesth Analg 2005; 100:580.</a></li><li><a class="nounderline abstract_t">Jaber S, Monnin M, Girard M, et al. Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial. Intensive Care Med 2016; 42:1877.</a></li><li><a class="nounderline abstract_t">Baillard C, Fosse JP, Sebbane M, et al. Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med 2006; 174:171.</a></li><li><a class="nounderline abstract_t">Rothen HU, Sporre B, Engberg G, et al. Prevention of atelectasis during general anaesthesia. Lancet 1995; 345:1387.</a></li><li><a class="nounderline abstract_t">Edmark L, Kostova-Aherdan K, Enlund M, Hedenstierna G. Optimal oxygen concentration during induction of general anesthesia. Anesthesiology 2003; 98:28.</a></li><li><a class="nounderline abstract_t">Patel A, Nouraei SA. Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways. Anaesthesia 2015; 70:323.</a></li><li><a class="nounderline abstract_t">Wimalasena Y, Burns B, Reid C, et al. Apneic oxygenation was associated with decreased desaturation rates during rapid sequence intubation by an Australian helicopter emergency medicine service. Ann Emerg Med 2015; 65:371.</a></li><li><a class="nounderline abstract_t">Ramachandran SK, Cosnowski A, Shanks A, Turner CR. Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration. J Clin Anesth 2010; 22:164.</a></li><li><a class="nounderline abstract_t">Sakles JC, Mosier JM, Patanwala AE, et al. First Pass Success Without Hypoxemia Is Increased With the Use of Apneic Oxygenation During Rapid Sequence Intubation in the Emergency Department. Acad Emerg Med 2016; 23:703.</a></li><li><a class="nounderline abstract_t">Oliveira J E Silva L, Cabrera D, Barrionuevo P, et al. Effectiveness of Apneic Oxygenation During Intubation: A Systematic Review and Meta-Analysis. Ann Emerg Med 2017; 70:483.</a></li><li><a class="nounderline abstract_t">Binks MJ, Holyoak RS, Melhuish TM, et al. Apneic oxygenation during intubation in the emergency department and during retrieval: A systematic review and meta-analysis. Am J Emerg Med 2017; 35:1542.</a></li><li><a class="nounderline abstract_t">Pavlov I, Medrano S, Weingart S. Apneic oxygenation reduces the incidence of hypoxemia during emergency intubation: A systematic review and meta-analysis. Am J Emerg Med 2017; 35:1184.</a></li><li><a class="nounderline abstract_t">FRUMIN MJ, EPSTEIN RM, COHEN G. Apneic oxygenation in man. Anesthesiology 1959; 20:789.</a></li><li><a class="nounderline abstract_t">Fraioli RL, Sheffer LA, Steffenson JL. Pulmonary and cardiovascular effects of apneic oxygenation in man. Anesthesiology 1973; 39:588.</a></li><li><a class="nounderline abstract_t">McNamara MJ, Hardman JG. Hypoxaemia during open-airway apnoea: a computational modelling analysis. Anaesthesia 2005; 60:741.</a></li><li><a class="nounderline abstract_t">High flow nasal vs high flow mask oxygen delivery: tracheal gas concentrations through a head extension airway model. Respiratory Care 2002; 47:1079.</a></li><li><a class="nounderline abstract_t">Taha SK, Siddik-Sayyid SM, El-Khatib MF, et al. Nasopharyngeal oxygen insufflation following pre-oxygenation using the four deep breath technique. Anaesthesia 2006; 61:427.</a></li><li><a class="nounderline abstract_t">Teller LE, Alexander CM, Frumin MJ, Gross JB. Pharyngeal insufflation of oxygen prevents arterial desaturation during apnea. Anesthesiology 1988; 69:980.</a></li><li><a class="nounderline abstract_t">Baraka AS, Taha SK, Siddik-Sayyid SM, et al. Supplementation of pre-oxygenation in morbidly obese patients using nasopharyngeal oxygen insufflation. Anaesthesia 2007; 62:769.</a></li><li class="breakAll">Levitan R.M. NO DESAT! (Nasal oxygen during efforts securing a tube). Emergency Physicians Monthly. Accessed from: http://epmonthly.com/article/no-desat/ (Accessed on December 28, 2017).</li><li><a class="nounderline abstract_t">Semler MW, Janz DR, Lentz RJ, et al. Randomized Trial of Apneic Oxygenation during Endotracheal Intubation of the Critically Ill. Am J Respir Crit Care Med 2016; 193:273.</a></li><li><a class="nounderline abstract_t">Pillai A, Daga V, Lewis J, et al. High-flow humidified nasal oxygenation vs. standard face mask oxygenation. Anaesthesia 2016; 71:1280.</a></li><li><a class="nounderline abstract_t">Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers. Aust Crit Care 2007; 20:126.</a></li><li><a class="nounderline abstract_t">Parke RL, Eccleston ML, McGuinness SP. The effects of flow on airway pressure during nasal high-flow oxygen therapy. Respir Care 2011; 56:1151.</a></li><li><a class="nounderline abstract_t">Piosik ZM, Dirks J, Rasmussen LS, et al. Exploring the limits of prolonged apnoea with high-flow nasal oxygen: an observational study. Anaesthesia 2021; 76:798.</a></li><li><a class="nounderline abstract_t">Mir F, Patel A, Iqbal R, et al. A randomised controlled trial comparing transnasal humidified rapid insufflation ventilatory exchange (THRIVE) pre-oxygenation with facemask pre-oxygenation in patients undergoing rapid sequence induction of anaesthesia. Anaesthesia 2017; 72:439.</a></li><li><a class="nounderline abstract_t">Lodenius Å, Piehl J, Östlund A, et al. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) vs. facemask breathing pre-oxygenation for rapid sequence induction in adults: a prospective randomised non-blinded clinical trial. Anaesthesia 2018; 73:564.</a></li><li><a class="nounderline abstract_t">Sjöblom A, Broms J, Hedberg M, et al. Pre-oxygenation using high-flow nasal oxygen vs. tight facemask during rapid sequence induction. Anaesthesia 2021; 76:1176.</a></li><li><a class="nounderline abstract_t">Wong DT, Dallaire A, Singh KP, et al. High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial. Anesth Analg 2019; 129:1130.</a></li><li><a class="nounderline abstract_t">Hua Z, Liu Z, Li Y, et al. Transnasal humidified rapid insufflation ventilatory exchange vs. facemask oxygenation in elderly patients undergoing general anaesthesia: a randomized controlled trial. Sci Rep 2020; 10:5745.</a></li><li><a class="nounderline abstract_t">Waters E, Kellner M, Milligan P, et al. The use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) in one hundred and five upper airway endoscopies. A case series. Clin Otolaryngol 2019; 44:1115.</a></li><li><a class="nounderline abstract_t">Lyons C, Callaghan M. Apnoeic oxygenation with high-flow nasal oxygen for laryngeal surgery: a case series. Anaesthesia 2017; 72:1379.</a></li><li><a class="nounderline abstract_t">Gustafsson IM, Lodenius Å, Tunelli J, et al. Apnoeic oxygenation in adults under general anaesthesia using Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) - a physiological study. Br J Anaesth 2017; 118:610.</a></li><li><a class="nounderline abstract_t">Booth AWG, Vidhani K, Lee PK, et al. The Effect of High-Flow Nasal Oxygen on Carbon Dioxide Accumulation in Apneic or Spontaneously Breathing Adults During Airway Surgery: A Randomized-Controlled Trial. Anesth Analg 2021; 133:133.</a></li><li><a class="nounderline abstract_t">Riva T, Pedersen TH, Seiler S, et al. Transnasal humidified rapid insufflation ventilatory exchange for oxygenation of children during apnoea: a prospective randomised controlled trial. Br J Anaesth 2018; 120:592.</a></li><li><a class="nounderline abstract_t">Humphreys S, Lee-Archer P, Reyne G, et al. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) in children: a randomized controlled trial. Br J Anaesth 2017; 118:232.</a></li><li><a class="nounderline abstract_t">Riva T, Greif R, Kaiser H, et al. Carbon Dioxide Changes during High-flow Nasal Oxygenation in Apneic Patients: A Single-center Randomized Controlled Noninferiority Trial. Anesthesiology 2022; 136:82.</a></li><li><a class="nounderline abstract_t">Sud A, Athanassoglou V, Anderson EM, Scott S. A comparison of gastric gas volumes measured by computed tomography after high-flow nasal oxygen therapy or conventional facemask ventilation. Anaesthesia 2021; 76:1184.</a></li><li><a class="nounderline abstract_t">Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019; 53.</a></li><li><a class="nounderline abstract_t">Ip M, Tang JW, Hui DS, et al. Airflow and droplet spreading around oxygen masks: a simulation model for infection control research. Am J Infect Control 2007; 35:684.</a></li><li><a class="nounderline abstract_t">Leung CCH, Joynt GM, Gomersall CD, et al. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. J Hosp Infect 2019; 101:84.</a></li></ol></div><div id="topicVersionRevision">Topic 113243 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2221412" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Preoxygenation in the elderly: a comparison of the four-maximal-breath and three-minute techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8110535" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Preoxygenation in healthy volunteers: a graph of oxygen "washin" using end-tidal oxygraphy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9059106" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : End-tidal oxygraphy and safe duration of apnoea in young adults and elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13630833" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Demonstration of aventilatory mass flow during ventilation and apnea in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15590254" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The incidence and risk factors for cardiac arrest during emergency tracheal intubation: a justification for incorporating the ASA Guidelines in the remote location.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16704612" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Routine pre-oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3578856" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Preoxygenation techniques: comparison of three minutes and four breaths.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12717151" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15488049" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Routine pre-oxygenation - a new 'minimum standard' of care?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2069238" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Arterial desaturation during induction in healthy adults: should preoxygenation be a routine?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22321104" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Difficult Airway Society Guidelines for the management of tracheal extubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22321104" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Difficult Airway Society Guidelines for the management of tracheal extubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23291626" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Situation awareness in anesthesia: concept and research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13725901" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The rate of rise of PaCO2 in the apneic anesthetized patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7194597" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Arterial oxygenation in conscious patients after 5 minutes and after 30 seconds of oxygen breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10485768" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Preoxygenation: comparison of maximal breathing and tidal volume breathing techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10485765" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Preoxygenation: best method for both efficacy and efficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4157184" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Arterial oxygen tension during apnoea in parturient women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8564655" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : [Effects of preoxygenation methods on the course of PaO2 and PaCO2 in anesthetic post-induction apnea].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28525518" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : High End-Tidal Oxygen Concentration Can Be a Misleading Sole Indicator of the Completeness of Preoxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17223799" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Fighting for breath: apnoea vs the anaesthetist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17223799" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Fighting for breath: apnoea vs the anaesthetist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20122589" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Preoxygenation by 8 deep breaths in 60 seconds using the Mapleson A (Magill), the circle system, or the Mapleson D system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17272254" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Preoxygenation with the Mapleson D system requires higher oxygen flows than Mapleson A or circle systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11323373" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Preoxygenation with tidal volume and deep breathing techniques: the impact of duration of breathing and fresh gas flow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9357902" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8777112" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A model to describe the rate of oxyhaemoglobin desaturation during apnoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11421834" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Frequency of haemoglobin desaturation with the use of succinylcholine during rapid sequence induction of anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11388524" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3592155" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pre-oxygenation and the parturient patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6402951" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pre-oxygenation--how long?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6466533" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Arterial oxygen saturation before intubation of the trachea. An assessment of oxygenation techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8672330" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Preoxygenation--the importance of a good face mask seal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10969302" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Efficacy of preoxygenation with tidal volume breathing. Comparison of breathing systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1935164" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Manual resuscitators and spontaneous ventilation--an evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16229689" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A prospective, randomised controlled trial comparing the efficacy of pre-oxygenation in the 20 degrees head-up vs supine position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21293885" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Preoxygenation with 20ºhead-up tilt provides longer duration of non-hypoxic apnea than conventional preoxygenation in non-obese healthy adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16143575" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1416130" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Preoxygenation of pregnant and nonpregnant women in the head-up versus supine position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18289231" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Pre-oxygenation in pregnancy: an investigation using physiological modelling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14508315" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Total oxygen uptake with two maximal breathing techniques and the tidal volume breathing technique: a physiologic study of preoxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16371614" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : When a leak is unavoidable, preoxygenation is equally ineffective with vital capacity or tidal volume breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1951996" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A comparison of different pre-oxygenation techniques in the elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17541073" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Efficacy of preoxygenation using tidal volume and deep breathing techniques with and without prior maximal exhalation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20404729" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Positive end-expiratory pressure improves end-expiratory lung volume but not oxygenation after induction of anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15105237" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prevention of atelectasis formation during the induction of general anesthesia in morbidly obese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14633570" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prevention of atelectasis formation during induction of general anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20116969" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : [Inspiratory support versus spontaneous breathing during preoxygenation in healthy subjects. A randomized, double blind, cross-over trial].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18931236" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25937647" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Effect of positive airway pressure during pre-oxygenation and induction of anaesthesia upon safe duration of apnoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14984521" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The effect of positive airway pressure during pre-oxygenation and induction of anaesthesia upon duration of non-hypoxic apnoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11437771" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Effectiveness of continuous positive airway pressure to enhance pre-oxygenation in morbidly obese women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15673897" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Positive end-expiratory pressure during induction of general anesthesia increases duration of nonhypoxic apnea in morbidly obese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27730283" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16627862" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7760608" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Prevention of atelectasis during general anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12502975" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Optimal oxygen concentration during induction of general anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25388828" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25536868" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Apneic oxygenation was associated with decreased desaturation rates during rapid sequence intubation by an Australian helicopter emergency medicine service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20400000" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26836712" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : First Pass Success Without Hypoxemia Is Increased With the Use of Apneic Oxygenation During Rapid Sequence Intubation in the Emergency Department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28712606" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Effectiveness of Apneic Oxygenation During Intubation: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28684195" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Apneic oxygenation during intubation in the emergency department and during retrieval: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28647137" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Apneic oxygenation reduces the incidence of hypoxemia during emergency intubation: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13825447" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Apneic oxygenation in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4761019" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Pulmonary and cardiovascular effects of apneic oxygenation in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16029221" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Hypoxaemia during open-airway apnoea: a computational modelling analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : High flow nasal vs high flow mask oxygen delivery: tracheal gas concentrations through a head extension airway model</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16674614" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Nasopharyngeal oxygen insufflation following pre-oxygenation using the four deep breath technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3195773" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Pharyngeal insufflation of oxygen prevents arterial desaturation during apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17635423" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Supplementation of pre-oxygenation in morbidly obese patients using nasopharyngeal oxygen insufflation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17635423" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Supplementation of pre-oxygenation in morbidly obese patients using nasopharyngeal oxygen insufflation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26426458" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Randomized Trial of Apneic Oxygenation during Endotracheal Intubation of the Critically Ill.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27734491" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : High-flow humidified nasal oxygenation vs. standard face mask oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17931878" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : High flow nasal oxygen generates positive airway pressure in adult volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21496369" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The effects of flow on airway pressure during nasal high-flow oxygen therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33179248" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Exploring the limits of prolonged apnoea with high-flow nasal oxygen: an observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28035669" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : A randomised controlled trial comparing transnasal humidified rapid insufflation ventilatory exchange (THRIVE) pre-oxygenation with facemask pre-oxygenation in patients undergoing rapid sequence induction of anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29330853" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) vs. facemask breathing pre-oxygenation for rapid sequence induction in adults: a prospective randomised non-blinded clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33599993" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Pre-oxygenation using high-flow nasal oxygen vs. tight facemask during rapid sequence induction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31584919" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32238855" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Transnasal humidified rapid insufflation ventilatory exchange vs. facemask oxygenation in elderly patients undergoing general anaesthesia: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31356730" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) in one hundred and five upper airway endoscopies. A case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29047136" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Apnoeic oxygenation with high-flow nasal oxygen for laryngeal surgery: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28403407" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Apnoeic oxygenation in adults under general anaesthesia using Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) - a physiological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32618626" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The Effect of High-Flow Nasal Oxygen on Carbon Dioxide Accumulation in Apneic or Spontaneously Breathing Adults During Airway Surgery: A Randomized-Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29452816" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Transnasal humidified rapid insufflation ventilatory exchange for oxygenation of children during apnoea: a prospective randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28100527" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) in children: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34758057" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Carbon Dioxide Changes during High-flow Nasal Oxygenation in Apneic Patients: A Single-center Randomized Controlled Noninferiority Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33651914" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : A comparison of gastric gas volumes measured by computed tomography after high-flow nasal oxygen therapy or conventional facemask ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30705129" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18063134" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Airflow and droplet spreading around oxygen masks: a simulation model for infection control research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30336170" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
